Who to call at INmune Bio Inc., and when
Fundz watches for the moments INmune Bio Inc. starts buying, and tells you who to reach.
- An alert the day INmune Bio Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at INmune Bio Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at INmune Bio Inc.. With Fundz connected, it knows.
INmune Bio Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
inmunebio.comAI Executive Summary
AI-powered analysis of 8-K filing content
At a November 18, 2025 special meeting, INmune Bio stockholders approved a one-time repricing of up to 5,511,000 stock options held by eligible employees and directors, reducing their exercise price to $1.50 per share. The change increases the retention value of existing awards and adds potential future dilution.
Key Takeaways
Stockholders approved a one-time Option Repricing on November 18, 2025, after the Board initially approved it on September 30, 2025.
Up to 5,511,000 options under the 2017, 2019, and Second Amended and Restated 2021 Stock Incentive Plans were eligible, limited to those with exercise prices above $1.50.
3 more takeaways
Related Filings (25)
25 more filings from INmune Bio Inc. in the last 90 days
Filing Overview
What This Means
INmune Bio Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.